CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics to Participate in Upcoming Investor Conferences

01 يونيو 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Presents New Data in Patients With Non-Obstructive HCM From Cohort 4 of REDWOOD-HCM in Late-Breaking Clinical Trial Session at The European Society of Cardiology Heart Failure 2023 Congress

20 مايو 2023 10:30:56 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Three Upcoming Presentations at the European Society of Cardiology Heart Failure 2023 Congress

15 مايو 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4021586

11 مايو 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Cytokinetics to Participate in the JMP Securities Life Sciences Conference

08 مايو 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Reports First Quarter 2023 Financial Results

04 مايو 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics to Hold Annual Meeting of Stockholders

03 مايو 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 مايو 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics to Announce First Quarter Results on May 4, 2023

20 أبريل 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics To Participate In The 22nd Annual Needham Virtual Healthcare Conference

10 أبريل 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 أبريل 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis

31 مارس 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Releases Inaugural Corporate Responsibility Report

27 مارس 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Cytokinetics to Participate in Upcoming Investor Conferences

06 مارس 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session

04 مارس 2023 10:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 مارس 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Reports Fourth Quarter 2022 Financial Results

01 مارس 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Receives Complete Response Letter From FDA for New Drug Application for Omecamtiv Mecarbil

28 فبراير 2023 17:31:51 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Three Upcoming Presentations at the American College of Cardiology 72nd Annual Scientific Session

24 فبراير 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

22 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire